Hims & Hers Health Inc. reported a first-quarter loss and sales that missed Wall Street estimates amid increasing competition in the weight-loss drug market.
Revenue was $608 million, the company said in a statement Monday, below the average analyst estimate of $617.5 million. The company reported a loss of 40 cents a share in the period, compared with profit of 20 cents a share a year ago.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.